Inibidores de CDK4/6 no câncer de mama HR+/HER2-
Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-

Released: August 19, 2024

Expiration: August 18, 2025

Activity

Progress
1
Course Completed